[go: up one dir, main page]

NO20083044L - Deteksjon av loselige adisponektinreseptorpeptider og anvendelse i diagnostikk og terapi - Google Patents

Deteksjon av loselige adisponektinreseptorpeptider og anvendelse i diagnostikk og terapi

Info

Publication number
NO20083044L
NO20083044L NO20083044A NO20083044A NO20083044L NO 20083044 L NO20083044 L NO 20083044L NO 20083044 A NO20083044 A NO 20083044A NO 20083044 A NO20083044 A NO 20083044A NO 20083044 L NO20083044 L NO 20083044L
Authority
NO
Norway
Prior art keywords
soluble
adisponectin
diagnostics
therapy
detection
Prior art date
Application number
NO20083044A
Other languages
English (en)
Other versions
NO345378B1 (no
Inventor
Michael J Pugia
Original Assignee
Siemens Healthcare Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siemens Healthcare Diagnostics Inc filed Critical Siemens Healthcare Diagnostics Inc
Publication of NO20083044L publication Critical patent/NO20083044L/no
Publication of NO345378B1 publication Critical patent/NO345378B1/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Den foreliggende oppfinnelse angår løselige C-terminale fragmenter av adiponektinreseptorene og deres anvendelse i diagnose og behandling av lidelser.
NO20083044A 2005-12-07 2006-12-04 Deteksjon av løselige adisponektinreseptorpeptider og anvendelse i diagnostikk og terapi NO345378B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74830505P 2005-12-07 2005-12-07
PCT/US2006/061555 WO2007120311A2 (en) 2005-12-07 2006-12-04 Detection of soluble adiponectin receptor peptides and use in diagnostics and therapeutics

Publications (2)

Publication Number Publication Date
NO20083044L true NO20083044L (no) 2008-09-01
NO345378B1 NO345378B1 (no) 2021-01-11

Family

ID=38609995

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083044A NO345378B1 (no) 2005-12-07 2006-12-04 Deteksjon av løselige adisponektinreseptorpeptider og anvendelse i diagnostikk og terapi

Country Status (11)

Country Link
US (3) US8093017B2 (no)
EP (1) EP1954312B1 (no)
JP (1) JP4927093B2 (no)
KR (1) KR20080075005A (no)
CN (1) CN101454024A (no)
AU (1) AU2006342086B2 (no)
BR (1) BRPI0619503A2 (no)
CA (1) CA2636129C (no)
ES (1) ES2463451T3 (no)
NO (1) NO345378B1 (no)
WO (1) WO2007120311A2 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1830421A3 (en) * 2006-03-03 2012-03-14 Semiconductor Energy Laboratory Co., Ltd. Light emitting device, manufacturing method of light emitting device, and sheet-like sealing material
US20080057590A1 (en) * 2006-06-07 2008-03-06 Mickey Urdea Markers associated with arteriovascular events and methods of use thereof
EP2469282A1 (en) * 2006-09-08 2012-06-27 University of Oxford Clinical diagnosis of hepatic fibrosis using a novel panel of human serum protein biomarkers
CN101743008A (zh) 2007-05-23 2010-06-16 西佳技术公司 用于治疗或预防登革热感染的抗病毒药
EP2215268B1 (en) 2007-11-30 2018-08-29 Siemens Healthcare Diagnostics Inc. Adiponectin receptor fragments and methods of use
JP5229866B2 (ja) * 2007-12-12 2013-07-03 国立大学法人広島大学 大腸癌、動脈硬化症、又はメタボリックシンドロームの検出方法
CN102388308B (zh) * 2009-04-23 2015-08-19 西门子医疗保健诊断公司 单体和二聚形式的脂连蛋白受体片段和使用方法
JP5813630B2 (ja) * 2009-05-14 2015-11-17 ザ チャンセラー，マスターズ アンド スカラーズ オブ ザ ユニバーシティ オブ オックスフォード 微量ヒト血漿タンパク質バイオマーカーの新規なパネルを使用した肝線維症の臨床診断
JP5731830B2 (ja) 2010-01-19 2015-06-10 パナソニック株式会社 面状発光装置
WO2012141792A2 (en) 2011-04-11 2012-10-18 Siemens Healthcare Diagnostics, Inc. Adiponectin receptor c-terminal fragments (ctf)-immunoglobulin
AU2017214469A1 (en) 2016-02-01 2018-07-26 Prevencio, Inc. Diagnostic and prognostic methods for cardiovascular diseases and events
SMT202200351T1 (it) * 2016-04-20 2022-09-14 New Frontier Labs Llc Esteri dell'acido azelaico nel trattamento della resistenza all'insulina

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0261076A (ja) 1988-08-29 1990-03-01 Furukawa Electric Co Ltd:The 放電加工用電極線の製造方法
WO1997033996A2 (en) 1996-03-11 1997-09-18 Bayer Corporation Human bikunin
NZ335864A (en) 1996-11-06 2001-09-28 Univ California Isolated tumor necrosis factor receptor releasing enzyme (TRRE), compositions comprising the enzyme and methods of the use in modulation of TNF levels
EP1002865A1 (en) 1998-10-30 2000-05-24 Sanofi-Synthelabo Adipose specific protein
US20040067490A1 (en) 2001-09-07 2004-04-08 Mei Zhong Therapeutic polypeptides, nucleic acids encoding same, and methods of use
JP2002061076A (ja) 2000-08-18 2002-02-28 Shinto Print Kk 吸着シートとその利用品
JPWO2002061076A1 (ja) 2001-02-01 2004-06-03 持田製薬株式会社 アディポネクチン関連蛋白質
WO2002072149A1 (en) 2001-03-14 2002-09-19 Oklahoma Medical Research Foundation Methods for reducing fat by administration of adiponectin
AU2003244237A1 (en) 2002-09-05 2004-03-29 Komed Co., Ltd. Monoclonal antibody against adiponectin, preparation method and use thereof
JP3955885B2 (ja) 2002-12-29 2007-08-08 日産化学工業株式会社 アディポネクチン受容体及びそれをコードする遺伝子
ATE440284T1 (de) 2003-01-09 2009-09-15 Beth Israel Hospital Verwendung von adiponectin zur diagnose von krebs
US20060286035A1 (en) * 2003-04-29 2006-12-21 Cytos Biotechnology Ag Methods and compositions for modulating the interaction between adiponectin and its receptor
US7435808B2 (en) 2003-06-25 2008-10-14 Bristol-Myers Squibb Company Polynucleotides encoding novel adiponectin receptor variant, AdipoR2v2
BRPI0507972A (pt) * 2004-02-23 2007-07-24 Tufts College composto ,composição farmacêutica , uso de um composto, método para inibição da atividade proteolìtica de uma enzima de clivagem pós prolina e composição farmacêutica embalada
BRPI0510613A (pt) 2004-05-03 2007-10-30 Omega Bio Pharma Ip3 Ltd cisteaminas para tratar complicações de hipercolesterolemia e diabete
ATE492651T1 (de) * 2005-11-10 2011-01-15 Bristol Myers Squibb Pharma Co Moesin, caveolin 1 und yes-assoziiertes protein 1 als prädiktive marker der reaktion auf dasatinib bei brustkrebs

Also Published As

Publication number Publication date
KR20080075005A (ko) 2008-08-13
CN101454024A (zh) 2009-06-10
WO2007120311A2 (en) 2007-10-25
NO345378B1 (no) 2021-01-11
BRPI0619503A2 (pt) 2011-10-04
WO2007120311A3 (en) 2008-01-31
AU2006342086B2 (en) 2012-11-01
JP2009518653A (ja) 2009-05-07
US8632990B2 (en) 2014-01-21
US8093017B2 (en) 2012-01-10
US20100143958A1 (en) 2010-06-10
JP4927093B2 (ja) 2012-05-09
EP1954312B1 (en) 2014-02-12
CA2636129A1 (en) 2007-10-25
ES2463451T3 (es) 2014-05-28
AU2006342086A1 (en) 2007-10-25
EP1954312A4 (en) 2009-03-25
EP1954312A2 (en) 2008-08-13
US20130149720A1 (en) 2013-06-13
CA2636129C (en) 2015-02-17
US20130196353A1 (en) 2013-08-01
US8846346B2 (en) 2014-09-30

Similar Documents

Publication Publication Date Title
NO20083044L (no) Deteksjon av loselige adisponektinreseptorpeptider og anvendelse i diagnostikk og terapi
NO20091413L (no) WNT-antagonister og deres anvendelse i diagnostiseringen og behandlingen av WNT-medierte forstyrrelser
MX2007013626A (es) Anticuerpos dirigidos contra el peptido beta amiloide y procedimientos que usan los mismos.
EA201070636A1 (ru) Ингибирование рецептора белка, стимулирующего макрофаги (ron), и способы его лечения
UA106771C2 (uk) Моноклональні антитіла до прогастрину та їх використання
UA109633C2 (uk) Антитіло людини проти тканинного фактора
EA201100062A1 (ru) Соединения и способы модулирования рецепторов, связанных с белком g
EA200900203A1 (ru) Избирательные модуляторы рецептора андрогенов, их аналоги, производные и применение
EA200802182A1 (ru) Модифицированные гуманизированные антитела против интерлейкина-18
NZ593474A (en) Compositions and methods for treatment of celiac disease
CO6390041A2 (es) Agentes y antagonistas fijaodres de notch y metodos para el uso de los mismos.
EA201290964A1 (ru) Пептидные конъюгаты агонистов рецептора glp-1 и их применение
EA201000265A1 (ru) Мутанты mcp-1 антагонисты гликозаминогликана и способы их применения
EA201000644A1 (ru) Антитела для лечения и профилактики болезни альцгеймера и их применение
MX2010008206A (es) Metodos y composiciones que utilizan polipeptidos de fusion de klotho-fgf.
EA201170136A1 (ru) Мультимасштабный метод конечных объемов для моделирования резервуара
NO20082345L (no) Selektive VPAC2 reseptorpeptidagonister
PH12014502507A1 (en) Anti-angiogenesis therapy for the treatment of breast cancer
EA200971131A1 (ru) Биомаркеры для прогнозирования чувствительности или отсутствия чувствительности к анти-фно агентам
EP3064509A3 (en) Anti-angiogenesis therapy for the treatment of ovarian cancer
UA101167C2 (ru) Фармацевтическая композиция, предназначенная для лечения глазной болезни
EA201070725A1 (ru) Бис-пиридилпиридоны как антагонисты рецептора 1 меланинконцентрирующего гормона
EA200701978A1 (ru) Способ получения опиоидных модуляторов
ATE486890T1 (de) Ephb-rezeptorbindende peptide
UA104714C2 (ru) Выделенный полинуклеотид brachyspira hyodysenteriae, кодирующий полипептид, и его применение

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees